Arkolith/Insider Trading/ITRM/Form 4

Dunne Michael W.

DirectorIterum Therapeutics plc (ITRM) · full profile →Form 4 · filed Mar 29, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 25, 2022Option exercise(M)10K—$0347K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 25, 2022Option exercise(M)10K—$00
Mar 25, 2022Grant(A)11K—$011K

Transaction Codes

M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-021542) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML